Literature DB >> 30022225

[Prognostic relevance of TIM3 in renal cell carcinoma].

P Stenzel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30022225     DOI： 10.1007/s00292-018-0462-6

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  4 in total

1.  Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

Authors:  Robert J Motzer; Nizar M Tannir; David F McDermott; Osvaldo Arén Frontera; Bohuslav Melichar; Toni K Choueiri; Elizabeth R Plimack; Philippe Barthélémy; Camillo Porta; Saby George; Thomas Powles; Frede Donskov; Victoria Neiman; Christian K Kollmannsberger; Pamela Salman; Howard Gurney; Robert Hawkins; Alain Ravaud; Marc-Oliver Grimm; Sergio Bracarda; Carlos H Barrios; Yoshihiko Tomita; Daniel Castellano; Brian I Rini; Allen C Chen; Sabeen Mekan; M Brent McHenry; Megan Wind-Rotolo; Justin Doan; Padmanee Sharma; Hans J Hammers; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-03-21       Impact factor: 91.245

2.  Prognostic implication of TIM-3 in clear cell renal cell carcinoma.

Authors:  J Yuan; B Jiang; H Zhao; Q Huang
Journal:  Neoplasma       Date:  2014       Impact factor: 2.575

3.  Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma.

Authors:  Kyu Seo Kim; Rishi R Sekar; Dattatraya Patil; Michelle A Dimarco; Haydn T Kissick; Mehmet A Bilen; Adeboye O Osunkoya; Viraj A Master
Journal:  Oncoimmunology       Date:  2018-01-10       Impact factor: 8.110

Review 4.  TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.

Authors:  Wenwen Du; Min Yang; Abbey Turner; Chunling Xu; Robert L Ferris; Jianan Huang; Lawrence P Kane; Binfeng Lu
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923
  4 in total
  1 in total

1.  Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.

Authors:  Chen Liu; Xuhui Zhang; Caoyang Hu; Xuezhi Liang; Xiaoming Cao; Dongwen Wang
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.